Literature DB >> 1495890

The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

J P McGee1, P N Shaw.   

Abstract

The pharmacokinetics of trilostane and one of its metabolites ketotrilostane are described and characterized in the rat following the separate intravenous administration of trilostane and ketotrilostane. It was noted during these studies that the parent compound and its metabolite undergo metabolic interconversion-trilostane producing ketotrilostane and ketotrilostane generating trilostane. This result means that trilostane is conserved in the body by interconversion--being metabolized to ketotrilostane and then subsequently back to the "parent" drug, trilostane.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495890     DOI: 10.1023/a:1015828027060

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays.

Authors:  A W Meikle; J A Weed; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

2.  EXCRETION AND THE ACCRUAL OF DRUG METABOLITES.

Authors:  A J CUMMINGS; B K MARTIN
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

3.  Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors:  W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

4.  Microbiological hydroxylation of steroids. 1. Proton magnetic resonance spectra of ketones, alcohols, and acetates in the androstane, pregnane, and oestrane series.

Authors:  J E Bridgeman; P C Cherry; A S Clegg; J M Evans; E R Jones; A Kasal; V Kumar; G D Meakins; Y Morisawa; E E Richards; P D Woodgate
Journal:  J Chem Soc Perkin 1       Date:  1970

5.  A liner mode of reversible metabolism and its application to bioavailability assessment.

Authors:  S Hwang; K C Kwan; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

6.  Studies on the metabolism of trilostane, an inhibitor of adrenal steroidogenesis.

Authors:  Y Mori; M Tsuboi; M Suzuki; A Saito; H Ohnishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-09       Impact factor: 1.645

7.  Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man.

Authors:  W F Ebling; S J Szefler; W J Jusko
Journal:  Drug Metab Dispos       Date:  1985 May-Jun       Impact factor: 3.922

8.  Metabolic clearance rate and interconversion of androgens and the influence of the free androgen fraction.

Authors:  A Vermeulen; S Andó
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

9.  Trilostane, an orally active inhibitor of steroid biosynthesis.

Authors:  G O Potts; J E Creange; H R Hardomg; H P Schane
Journal:  Steroids       Date:  1978-09       Impact factor: 2.668

10.  The bioavailability and metabolism of trilostane in normal subjects, a comparative study using high pressure liquid chromatographic and quantitative cytochemical assays.

Authors:  D T Robinson; R J Earnshaw; R Mitchell; P Powles; R S Andrews; W R Robertson
Journal:  J Steroid Biochem       Date:  1984-11       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.